BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22699695)

  • 1. Current concepts in the imaging of uterine sarcoma.
    Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
    Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcomas 2013.
    Sutton G
    Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic factors in uterine sarcoma.
    Gadducci A
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine sarcomas: clinical presentation and MRI features.
    Santos P; Cunha TM
    Diagn Interv Radiol; 2015; 21(1):4-9. PubMed ID: 25347940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the treatment of sarcomas in gynecology.
    Lange SS; Novetsky AP; Powell MA
    Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
    Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
    Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Concepts in the Imaging of Uterine Sarcomas.
    Petrocelli R; Hindman N; Reinhold C
    Radiol Clin North Am; 2023 Jul; 61(4):627-638. PubMed ID: 37169428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
    Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
    Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
    Gao Y; Meng H; Zhang Y; Jiao T; Hui N
    Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
    Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
    Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma.
    Ludovisi M; Moro F; Pasciuto T; Di Noi S; Giunchi S; Savelli L; Pascual MA; Sladkevicius P; Alcazar JL; Franchi D; Mancari R; Moruzzi MC; Jurkovic D; Chiappa V; Guerriero S; Exacoustos C; Epstein E; Frühauf F; Fischerova D; Fruscio R; Ciccarone F; Zannoni GF; Scambia G; Valentin L; Testa AC
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):676-687. PubMed ID: 30908820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis.
    Pannier D; Cordoba A; Ryckewaert T; Robin YM; Penel N
    Crit Rev Oncol Hematol; 2019 Nov; 143():62-66. PubMed ID: 31494310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status of Magnetic Resonance Imaging in Patients with Malignant Uterine Neoplasms: A Review.
    Huang YT; Huang YL; Ng KK; Lin G
    Korean J Radiol; 2019 Jan; 20(1):18-33. PubMed ID: 30627019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of uterine sarcomas.
    Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
    Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.